India·Source-based summary
Bharat Biotech arm Nucelion, VeGen Bioto partner for CAR-T therapy
Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma
This is a source-based summary, not original reporting by Ebenezer journalists. Source: The Hindu. Ebenezer published 21 Oct 2026, 09:50 am. Editorial policy.
Read the original report on The Hindu →India — The Hindu


